‘Ego-Dissolving’ Psychedelic Drugs Could Improve Mental Health
From Medical Xpress: Researchers have proposed that psychedelic drugs such as LSD and magic mushrooms may help some people with anxiety, depression, and addiction by dissolving...
When Legal Drugs Harm and Illegal Drugs Help
From Scientific American: In a day and age when people are increasingly becoming addicted to prescription drugs, and increasingly helped by the therapeutic effects of illicit...
Rise in Psychiatric Prescriptions With NOS Diagnosis
A “not otherwise specified” (NOS) diagnosis is often used when an individual may have some symptoms related to a psychiatric diagnosis but does not meet enough criteria to warrant a particular diagnosis. A new study, published online ahead of print in Psychiatric Services, reveals that the proportion of mental health visits resulting in such NOS diagnoses rose to nearly fifty percent, and that these diagnoses do not result in more conservative psychiatric drug prescriptions.
Sunday History Channel: Seventy-five Years of Psychedelic Psychiatry
Mo Costandi provides a brief history in The Guardian of research activities using psychedelic substances such as LSD for psychiatric and psychotherapeutic purposes. Costandi...
“The Manual of Psychedelic Support”
-Zevic Mishor writes about the development and release of a free guide to supporting people through extreme states induced by the use of psychedelic drugs.
The Important Drugs Debate Question That Nobody’s Asking
In this piece for Vice, Max Daly explores the impact of societal attitudes toward drug use and drug users on the drug policy debate over prohibition...
“Warning Over Ketamine Use for Depression”
The Daily Telegraph reports on a warning published in the Medical Journal of Australia that urges doctors not to “jump the gun in prescribing patients the drug ketamine to treat depression.”
Top Psychiatrist Fired In “Political” Row Over PTSD-Marijuana Study
A psychiatrist at the University of Arizona was fired after state Republican Senators criticized her work to university officials, according to the New York...
The Psychedelic Renaissance is Here. Will it Last This Time?
From Massive: Increasing evidence suggests that psychedelics may revolutionize mental health care. In order for this "psychedelic renaissance" to last, scientists and citizens will need...
“Flimsy Evidence” for Esketamine as Depression Treatment
A new article documents the “flimsy evidence” behind the recent FDA approval of the party drug esketamine for the treatment of depression.
New Study Investigates Cannabidiol (CBD) for Psychosis
A new study examines the effects of CBD as an adjunct therapy to antipsychotic medication for patients diagnosed with schizophrenia.
Can Psychedelics Help End Addictions with One Dose?
Q13 Fox News discusses recent research giving psychedelics to people struggling with alcohol or cigarettes. David Nutt, an Imperial College London neuro-psychopharmacologist "thinks psilocybin...
Researchers Describe “Mind-blowing” Findings With Psychedelics
-Michael Pollan visits the resurgence of interest in the psychotherapeutic properties of psychedelic drugs in an essay in The New Yorker.
Ketamine for Harmful Drinking: A Look at the Data
New research contends that ketamine can reduce problematic alcohol use but does the data support the claims?
British Government Plans to Illegalize All Unapproved Psychoactive Substances
A Kings College London psychiatrist worries what broad new British restrictions on psychoactive substances could mean for psychedelic research.
What Are “Hard” and “Soft” Drugs?
From Neuroskeptic: A new paper examines the often arbitrary distinction between "hard" and "soft" drugs, recommending that scientists avoid using these classifications in research publications.
Article →
“FDA Forced to Release Adverse Event Reports on Psychiatric Drugs”
Following a lawsuit brought by Andrew Thibault of Parents Against Pharmaceutical Abuse (PAPA), the FDA has produced adverse event and severe adverse event reports...
Tripping for Knowledge: The Psychedelic Epistemologist
In this interview for 3:AM Magazine, Chris Letheby argues that even though psychedelics may induce delusions or imaginary phenomena, their use can also lead to accurate...
Psychedelic Use Associated with Reductions in Suicidal Tendencies
People who have taken a psychedelic drug at least once have less suicidal thinking than the general population.
“Scientists Push to Renew Psychedelic Drug Research for Psychiatry”
-CBC Radio interviews UK neuropsychopharmacologist David Nutt, Mark Haden of MAPS, and historian Erika Dyck about the past and present politics and science of psychedelic research.
“FDA Agrees to New Trials for Ecstasy as Relief for PTSD Patients”
Last week, the FDA gave permission for ecstasy to move into Phase 3 clinical trials for the treatment of PTSD. “If they can keep...
New Study Casts Doubt on Efficacy of Ketamine for Depression
A new study, published this month in the Journal of Affective Disorders, investigated the effectiveness of weekly intravenous ketamine injections as a treatment for...
“Healing with MDMA-assisted Psychotherapy” and Other Psychedelic Stories
The Multi-Disciplinary Association for Psychedelic Studies' Winter 2014 Bulletin is freely available. Among other articles, the issue includes a personal story of a patient,...
Doctors Tortured Patients at Ontario Mental-Health Centre
From The Globe and Mail: A judge has recently ruled that patients at a mental health facility in Ontario were tortured by doctors over a...
British Psychiatrists Advocate Psychedelics for Depression
The journal Therapeutic Advances in Psychopharmacology has published a review of what is known about psychedelic drugs' biochemical effects in the human brain, their...
